middle.news
How Is Imagion Biosystems Advancing Its MagSense® Breast Cancer Imaging Agent?
9:37am on Tuesday 29th of July, 2025 AEST
•
Healthcare
Read Story
How Is Imagion Biosystems Advancing Its MagSense® Breast Cancer Imaging Agent?
9:37am on Tuesday 29th of July, 2025 AEST
Key Points
Pre-IND briefing submitted and positively received by FDA
Manufacturing preparations underway for MagSense® HER2 imaging agent
Principal Investigator appointed for upcoming Phase 2 study
Master Service Agreement signed with Biosensis Ltd to optimize R&D costs
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Imagion Biosystems (ASX:IBX)
OPEN ARTICLE